Journal of Advanced Biotechnology and Experimental Therapeutics (Dec 2023)

Association of serum level of interleukin-33 and insulin resistance in overt and subclinical hypothyroidism patients

  • Zainab Abdul Hussein Jabbar,
  • Hanaa Addai Ali,
  • Rawaa Adday Ali,
  • Mohauman Mohammed Majeed AlRufaie

DOI
https://doi.org/10.5455/jabet.2023.d150
Journal volume & issue
Vol. 6, no. 3
pp. 575 – 583

Abstract

Read online

Hypothyroidism is a condition that occurs when the thyroid gland fails to produce an adequate amount of the hormone thyroid, as a result of factors for example hypothalamic or pituitary gland disease, common tissue resistance to thyroid hormones, and thyroid gland diseases. It's the most prevalent thyroid disorder. Interleukin-33 (IL-33) is a nuclear cytokine of the IL-1 family members that is abundantly expressed during homeostasis and inflammation in endothelial, epithelial, and fibroblast-like cells. It is worth noting that higher IL33 levels have been associated with insulin resistance. Aims the study: Its purpose was to examine the correlation between insulin resistance and IL33 in patients with hypothyroidism by measuring their IL33 levels. In a case-control study, 180 people were recruited and split into three categories: those with overt hypothyroidism (60), those with subclinical hypothyroidism (60), and those who were otherwise healthy (60). were of a similar age range to the patient (between 20 and 55), with 55.5% female participants and 44.5% male participants. [ J Adv Biotechnol Exp Ther 2023; 6(3.000): 575-583]

Keywords